Drug intelligence / Profile preview

SVV-GFP

Development stage
Preclinical
Lead developer
Methodist Hospital Research Institute
Modality
Gene Silencing → Gene Therapies, Oncolytic Viruses → Oncolytic Therapeutics, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
Administration
Intravenous
01

Overview

SVV-GFP is a recombinant Seneca Valley Virus (SVV-001) engineered to express Green Fluorescent Protein (GFP). It is an oncolytic picornavirus that exhibits high specificity for certain tumor types, particularly those with neuroendocrine features. In the context of glioblastoma, SVV-GFP is used as a diagnostic imaging agent to label infiltrative tumor cells in vivo following intravenous administration. This allows for real-time, image-guided fluorescent endomicroscopy during surgery to detect microscopic tumor clusters that are otherwise invisible to standard imaging modalities. The virus selectively infects and replicates in tumor cells, leading to the expression of GFP, which serves as a fluorescent marker for detection.

Other names
Seneca Valley Virus-GFPSVV-001-GFPSVV001-GFPSVV 001-GFP
02

Targets

ANTXR1 (Anthrax toxin receptor 1)

Beyond the preview

Go deeper on SVV-GFP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SVV-GFP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call